These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21573399)

  • 1. Molecular events in the initiation and progression of bladder-cancer (review).
    Stadler W
    Int J Oncol; 1993 Oct; 3(4):549-57. PubMed ID: 21573399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].
    Mikhailenko DS; Nemtsova MV
    Urologiia; 2016 Feb; (1):100-105. PubMed ID: 28247712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress of oncogene and tumor suppressor gene in bladder cancer.
    Zhang X; Han C; He J
    Panminerva Med; 2015 Dec; 57(4):191-200. PubMed ID: 25634585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology of bladder cancer.
    Borland RN; Brendler CB; Isaacs WB
    Hematol Oncol Clin North Am; 1992 Feb; 6(1):31-9. PubMed ID: 1556051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular genetic model of human bladder carcinogenesis.
    Reznikoff CA; Kao C; Messing EM; Newton M; Swaminathan S
    Semin Cancer Biol; 1993 Jun; 4(3):143-52. PubMed ID: 8318690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors.
    Sidransky D; Messing E
    Urol Clin North Am; 1992 Nov; 19(4):629-39. PubMed ID: 1441021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy.
    Spandidos DA; Liloglou T; Field JK
    Stem Cells; 1993 May; 11(3):194-8. PubMed ID: 8318905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms and pathways in bladder cancer development and progression.
    Jung I; Messing E
    Cancer Control; 2000; 7(4):325-34. PubMed ID: 10895126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biologic aspects of human prostatic carcinoma.
    Netto GJ; Humphrey PA
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S57-64. PubMed ID: 7942612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1996 May; 8(3):259-63. PubMed ID: 8794154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory microenvironment in the initiation and progression of bladder cancer.
    Sui X; Lei L; Chen L; Xie T; Li X
    Oncotarget; 2017 Nov; 8(54):93279-93294. PubMed ID: 29190997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental factors and genetic susceptibility promote urinary bladder cancer.
    Volanis D; Kadiyska T; Galanis A; Delakas D; Logotheti S; Zoumpourlis V
    Toxicol Lett; 2010 Mar; 193(2):131-7. PubMed ID: 20051252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical prognostic markers in bladder cancer.
    Ioachim E; Stavropoulos NE; Charalabopoulos K; Agnantis NJ
    J BUON; 2002; 7(3):207-16. PubMed ID: 17918790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways in bladder cancer.
    Williams SG; Stein JP
    Urol Res; 2004 Dec; 32(6):373-85. PubMed ID: 15551095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways of urothelial development and bladder tumorigenesis.
    Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
    Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?
    Shinohara N; Koyanagi T
    Urol Res; 2002 Oct; 30(5):273-81. PubMed ID: 12389114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
    Aunoble B; Sanches R; Didier E; Bignon YJ
    Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.